KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
15.35
-0.67 (-4.18%)
Jan 26, 2026, 11:40 AM EST - Market open
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $775.89 million as of January 26, 2026. Its market cap has increased by 79.23% in one year.
Market Cap
775.89M
Enterprise Value
756.75M
1-Year Change
79.23%
Ranking
Category
Stock Price
$15.35
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $775.89M, an increase of 500.07%. That is a compound annual growth rate of 18.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 809.80M | -0.80% |
| Dec 31, 2025 | 816.30M | 95.01% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
| Apr 9, 2015 | 129.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 869.15M |
| Bright Minds Biosciences | 851.32M |
| Omeros | 845.84M |
| Valneva SE | 837.21M |
| Arvinas | 827.85M |
| enGene Holdings | 815.20M |
| MapLight Therapeutics | 784.67M |
| Prime Medicine | 784.28M |